$CAPR
CAPRICOR THERAPEUTICS, INC.

2014 Q1 Form 10-K Financial Statement

#000114420414019617 Filed on March 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2012 Q4 2012
Revenue $1.042M $1.700M $1.900M
YoY Change 346.51% 750.0% 40.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $850.0K $30.00K $1.360M
YoY Change 80.85% -94.23% -35.85%
% of Gross Profit
Research & Development $1.375M $1.660M $2.634M
YoY Change 15.41% 23.88% -36.37%
% of Gross Profit
Depreciation & Amortization $6.465K $20.00K $20.34K
YoY Change 5.64% 103.37%
% of Gross Profit
Operating Expenses $2.227M $1.680M $3.999M
YoY Change 33.71% -9.68% -36.02%
Operating Profit -$1.185M -$2.100M
YoY Change -17.23%
Interest Expense $25.33K $30.00K $0.00
YoY Change 582.48% -100.0%
% of Operating Profit
Other Income/Expense, Net -$25.17K -$430.0K $28.79K
YoY Change -265.86% 187.85%
Pretax Income -$1.210M -$380.0K -$2.070M
YoY Change -14.79% -77.11% -57.58%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.211M -$380.0K -$2.071M
YoY Change -14.57% -77.11% 80.22%
Net Earnings / Revenue -116.22% -22.35% -109.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.034M -$101.9K -$2.091M
COMMON SHARES
Basic Shares Outstanding 11.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2012 Q4 2012
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.31M $4.363M $4.360M
YoY Change 4488.06% 319.5% 319.23%
Cash & Equivalents $12.98M $170.1K $170.0K
Short-Term Investments $326.2K $4.193M $4.190M
Other Short-Term Assets $730.0K $40.00K $40.00K
YoY Change 563.64% -85.19% -85.19%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $14.03M $5.193M $5.190M
YoY Change 3407.74% 296.28% 296.18%
LONG-TERM ASSETS
Property, Plant & Equipment $163.5K $33.94K $30.00K
YoY Change 248.35% 200.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $50.00K $51.94K $20.00K
YoY Change 400.0% 0.0% -60.0%
Total Long-Term Assets $1.946M $230.3K $230.0K
YoY Change 9628.8% 273.43% 283.33%
TOTAL ASSETS
Total Short-Term Assets $14.03M $5.193M $5.190M
Total Long-Term Assets $1.946M $230.3K $230.0K
Total Assets $15.98M $5.424M $5.420M
YoY Change 3703.98% 295.26% 295.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.000M $182.9K $430.0K
YoY Change 669.23% -58.22% -10.42%
Accrued Expenses $130.0K $20.00K $20.00K
YoY Change -35.0% -66.67% -66.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.299M $529.2K $530.0K
YoY Change 869.12% -2.27% -1.85%
LONG-TERM LIABILITIES
Long-Term Debt $3.960M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.380M $0.00 $0.00
YoY Change 1700.0%
Total Long-Term Liabilities $11.34M $0.00 $0.00
YoY Change 2665.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.299M $529.2K $530.0K
Total Long-Term Liabilities $11.34M $0.00 $0.00
Total Liabilities $17.64M $529.2K $530.0K
YoY Change 1563.79% -2.01% -1.85%
SHAREHOLDERS EQUITY
Retained Earnings -$46.71M
YoY Change 4.22%
Common Stock $11.69K $10.35K
YoY Change -73.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.659M $4.894M $4.890M
YoY Change
Total Liabilities & Shareholders Equity $15.98M $5.424M $5.420M
YoY Change 3703.98% 295.26% 295.62%

Cashflow Statement

Concept 2014 Q1 2012 Q4 2012
OPERATING ACTIVITIES
Net Income -$1.211M -$380.0K -$2.071M
YoY Change -14.57% -77.11% 80.22%
Depreciation, Depletion And Amortization $6.465K $20.00K $20.34K
YoY Change 5.64% 103.37%
Cash From Operating Activities $11.34M -$110.0K -$2.060M
YoY Change -1061.02% -92.99% -55.7%
INVESTING ACTIVITIES
Capital Expenditures $92.90K -$100.0K $13.43K
YoY Change 2854.87%
Acquisitions
YoY Change
Other Investing Activities $2.257K -$4.210M -$4.210M
YoY Change -99.5%
Cash From Investing Activities -$90.00K -$4.320M -$4.320M
YoY Change -120.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 3.810M 5.000M
YoY Change -100.0% 116.45%
NET CHANGE
Cash From Operating Activities 11.34M -110.0K -2.060M
Cash From Investing Activities -90.00K -4.320M -4.320M
Cash From Financing Activities 0.000 3.810M 5.000M
Net Change In Cash 11.25M -620.0K -1.380M
YoY Change 10127.27% -60.51% -41.03%
FREE CASH FLOW
Cash From Operating Activities $11.34M -$110.0K -$2.060M
Capital Expenditures $92.90K -$100.0K $13.43K
Free Cash Flow $11.25M -$10.00K -$2.073M
YoY Change -1050.61% -99.36% -55.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Assets Current
AssetsCurrent
3680840 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170106 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
222763 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1729537 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38042 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
5193252 USD
CY2012Q4 us-gaap Assets
Assets
5423590 USD
CY2013Q4 us-gaap Assets
Assets
5537907 USD
CY2012Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
264707 USD
CY2013Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1506509 USD
CY2012Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
75072 USD
CY2013Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
41855 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
529167 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2052922 USD
CY2012Q4 us-gaap Liabilities
Liabilities
529167 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2062643 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6144001 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32475 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26923 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
164732 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
332347 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
263593 USD
CY2013Q4 us-gaap Liabilities
Liabilities
6072789 USD
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10351294 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
10351 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
11687 USD
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11687747 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3679814 shares
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12114689 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15552946 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
7206611 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
16098535 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4894423 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-534882 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5423590 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5537907 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10351294 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11687747 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.51
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.67
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1186672 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4888519 shares
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3858 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13129874 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13428 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56115 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
284923 USD
CY2012 capr Proceeds From Reverse Merger
ProceedsFromReverseMerger
0 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2535426 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.37
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.31
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2634222 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5197178 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11499595 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1364582 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2208955 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6953667 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
3998804 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
7406133 USD
us-gaap Operating Expenses
OperatingExpenses
18453262 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-2100040 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-6902900 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-14272292 USD
CY2012 us-gaap Interest Expense
InterestExpense
0 USD
CY2013 us-gaap Interest Expense
InterestExpense
58134 USD
us-gaap Interest Expense
InterestExpense
58134 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28785 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1989024 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1826243 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-2071255 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8891924 USD
us-gaap Net Income Loss
NetIncomeLoss
-16098535 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9945251 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10501416 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4888519 shares
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y2M19D
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.51
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2535426 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.67
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20337 USD
us-gaap Share Based Compensation
ShareBasedCompensation
666123 USD
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2013 capr Proceeds From Reverse Merger
ProceedsFromReverseMerger
-664 USD
capr Proceeds From Reverse Merger
ProceedsFromReverseMerger
-664 USD
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
226998 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4441519 USD
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4114045 USD
CY2012 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-4317499 USD
CY2013 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
3778366 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-782507 USD
CY2012 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
5000000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1559431 USD
CY2013 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
3925066 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
15641918 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1380142 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1729537 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1550248 USD
CY2005Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012 us-gaap Interest Paid
InterestPaid
0 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
CAPRICOR THERAPEUTICS, INC.
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001133869
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
CAPR
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11690859 shares
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
1698139 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21795 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20815 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-980 USD
CY2012 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2093050 USD
CY2013 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8871109 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-16099515 USD
CY2012 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
28785 USD
CY2013 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
-11890 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
150891 USD
CY2012 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1919000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1919000 USD
CY2013Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="left">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="left">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts and disclosures. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4192726 USD
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
326494 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1401859 USD
CY2012Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
767163 USD
CY2013Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
0 USD
CY2012Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
25215 USD
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
187 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
29623 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
38850 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64558 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80429 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
98501 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154616 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33943 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74187 USD
CY2012Q4 us-gaap Loans Payable
LoansPayable
0 USD
CY2013Q4 us-gaap Loans Payable
LoansPayable
3961733 USD
CY2012Q4 us-gaap Deposit Assets
DepositAssets
18088 USD
CY2013Q4 us-gaap Deposit Assets
DepositAssets
25728 USD
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
24904 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
122416 USD
CY2012Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
0 USD
CY2013Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
58134 USD
CY2012Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
0 USD
CY2013Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
4019867 USD
CY2012Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
2211 USD
CY2013Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21795 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-980 USD
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 USD
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1500000 USD
CY2012Q4 us-gaap Marketable Securities
MarketableSecurities
4192726 USD
CY2013Q4 us-gaap Marketable Securities
MarketableSecurities
326494 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178307 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
227207 USD
CY2012Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
0 USD
CY2013Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
29945 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
68878 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
115766 USD
CY2012Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
0 USD
CY2013Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
6722 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28145 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.18 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2012 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y9M29D
CY2012 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
25215 USD
CY2013 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-25028 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
187 USD
CY2012 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
8980 USD
CY2013 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
5105 USD
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
23193 USD
CY2012 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
77149 USD
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
974710 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1239006 USD
CY2012 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
0 USD
CY2013 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
1401859 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
1401859 USD
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4214521 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4114045 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
88908 USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3707 USD
CY2012 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
0 USD
CY2013 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
97512 USD
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
122416 USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
58134 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
58134 USD
CY2013 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2013Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 capr Unamortised Patents Balance
UnamortisedPatentsBalance
194732 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4330 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4330 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
297196 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4330 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4330 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4330 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4330 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4330 USD
CY2013 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1500000 USD
CY2012 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2013 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21795 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-980 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20815 USD
CY2012Q4 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
164484 USD
CY2013Q4 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
382142 USD
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
1836495 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
863168 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
252552 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
911771 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
1788974 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1655152 USD
CY2005Q3 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2006 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3008000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2006 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
86 USD
CY2007 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
71 USD
CY2008 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
37 USD
CY2009 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
69 USD
CY2010 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
57 USD
CY2011 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
29 USD
CY2012 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
26 USD
CY2013 capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
1 USD
capr Interest On Subscription Receivables
InterestOnSubscriptionReceivables
36 USD
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-1171419 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-979076 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-630859 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-148970 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-1055748 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-1149320 USD
us-gaap Net Income Loss
NetIncomeLoss
36 USD
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5820 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16422 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8251 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24163 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15527 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
332347 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
263593 USD
CY2008 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3858 USD
CY2009 capr Stock And Warrants Issued For Cash Value
StockAndWarrantsIssuedForCashValue
800007 USD
CY2010 capr Stock And Warrants Issued For Cash Value
StockAndWarrantsIssuedForCashValue
2000000 USD
CY2011 capr Stock And Warrants Issued For Cash Value
StockAndWarrantsIssuedForCashValue
1000000 USD
CY2012 capr Stock And Warrants Issued For Cash Value
StockAndWarrantsIssuedForCashValue
5000000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
91155 USD
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-21795 USD
CY2013 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20815 USD
CY2013 capr Proceeds From Subscription Receivables
ProceedsFromSubscriptionReceivables
2212 USD
CY2013 capr Stock Issued During Period Value For Reverse Merger Transaction
StockIssuedDuringPeriodValueForReverseMergerTransaction
3176000 USD
CY2012 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
359547 USD
CY2013 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
-767163 USD
capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
0 USD
CY2012 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
26684 USD
CY2013 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
161617 USD
capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
199659 USD
CY2012 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
4554 USD
CY2013 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
217658 USD
capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
382142 USD
CY2012 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-5349 USD
CY2013 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-33217 USD
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
41855 USD
CY2012 capr Payments For Patents
PaymentsForPatents
89550 USD
CY2013 capr Payments For Patents
PaymentsForPatents
53230 USD
capr Payments For Patents
PaymentsForPatents
259682 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3925066 USD
capr Payment Of Preferred Stock And Warrant Issuance Cost
PaymentOfPreferredStockAndWarrantIssuanceCost
91155 USD
CY2013 capr Number Of Rights Offer For Each Share As Per Merger Agreement
NumberOfRightsOfferForEachShareAsPerMergerAgreement
2.07 shares
CY2012Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
4400000 USD
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
2100000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3925066 USD
CY2012 capr Payment Of Preferred Stock And Warrant Issuance Cost
PaymentOfPreferredStockAndWarrantIssuanceCost
0 USD
CY2013 capr Payment Of Preferred Stock And Warrant Issuance Cost
PaymentOfPreferredStockAndWarrantIssuanceCost
0 USD
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
1550000 USD
CY2012Q1 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
195500 USD
CY2013 capr Class Of Warrant Or Right Assumed From Merger Weighted Average Exercise Price
ClassOfWarrantOrRightAssumedFromMergerWeightedAverageExercisePrice
63.33
CY2013 capr Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
2.27
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
17.20
CY2013Q4 capr Leases Monthly Payments For First Twelve Months
LeasesMonthlyPaymentsForFirstTwelveMonths
16620 USD
CY2013Q4 capr Leases Monthly Payments For Second Twelve Months
LeasesMonthlyPaymentsForSecondTwelveMonths
17285 USD
CY2013Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3274631 USD
CY2013Q4 capr Accrued Milestone Payments
AccruedMilestonePayments
100000 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
664 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
25639 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
1500000 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
269303 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
1257000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
1919000 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
3176000 USD
CY2013Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
251044 shares
CY2013Q4 capr Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
251044 shares
CY2013Q4 capr Strike Price Of Warrants Issued To Purchase Common Stock
StrikePriceOfWarrantsIssuedToPurchaseCommonStock
2.2725
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.60
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.53
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1733599 shares
CY2013 capr Class Of Warrant Or Right Cancelled
ClassOfWarrantOrRightCancelled
1733599 shares
CY2013 capr Class Of Warrant Or Right Assumed From Merger
ClassOfWarrantOrRightAssumedFromMerger
81237 shares
CY2013 capr Shares Stock Options Assumed From Merger
SharesStockOptionsAssumedFromMerger
22033 shares
CY2013 capr Shares Stock Option Assumed From Merger Weighted Average Exercise Price
SharesStockOptionAssumedFromMergerWeightedAverageExercisePrice
34.15
CY2013 capr Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
251044 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
332281 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.38
CY2013 capr Class Of Warrant Or Right Cancelled Weighted Average Exercise Price
ClassOfWarrantOrRightCancelledWeightedAverageExercisePrice
3.38
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5413413 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5220800 shares

Files In Submission

Name View Source Status
v372462_10k.htm Edgar Link pending
0001144204-14-019617-index-headers.html Edgar Link pending
0001144204-14-019617-index.html Edgar Link pending
0001144204-14-019617.txt Edgar Link pending
0001144204-14-019617-xbrl.zip Edgar Link pending
capr-20131231.xml Edgar Link completed
capr-20131231.xsd Edgar Link pending
capr-20131231_cal.xml Edgar Link unprocessable
capr-20131231_def.xml Edgar Link unprocessable
capr-20131231_lab.xml Edgar Link unprocessable
capr-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.gif Edgar Link pending
image_001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v372462_ex10-10.htm Edgar Link pending
v372462_ex10-11.htm Edgar Link pending
v372462_ex10-31.htm Edgar Link pending
v372462_ex10-32.htm Edgar Link pending
v372462_ex10-33.htm Edgar Link pending
v372462_ex10-34.htm Edgar Link pending
v372462_ex10-35.htm Edgar Link pending
v372462_ex10-36.htm Edgar Link pending
v372462_ex10-37.htm Edgar Link pending
v372462_ex10-38.htm Edgar Link pending
v372462_ex10-39.htm Edgar Link pending
v372462_ex10-40.htm Edgar Link pending
v372462_ex10-41.htm Edgar Link pending
v372462_ex10-42.htm Edgar Link pending
v372462_ex10-43.htm Edgar Link pending
v372462_ex10-44.htm Edgar Link pending
v372462_ex10-7.htm Edgar Link pending
v372462_ex10-8.htm Edgar Link pending
v372462_ex10-9.htm Edgar Link pending
v372462_ex21-1.htm Edgar Link pending
v372462_ex23-1.htm Edgar Link pending
v372462_ex31-1.htm Edgar Link pending
v372462_ex31-2.htm Edgar Link pending
v372462_ex32-1.htm Edgar Link pending
v372462_ex32-2.htm Edgar Link pending